Status: Recruiting
Pan-tumor MRD Study
The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select solid tumors. The information collected will be used to develop tests to better understand cancer, for example, to improve cancer detection and to assess the risk of cancer coming back. Participants will receive routine standard of care from their doctor and their involvement is expected to last for approximately five and a half (5.5) years.
Participants needed: 1,350
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Paradigm HealthUpdated: Aug 14, 2025Locations: 2
Eligibility criteria
Age 18 years or older. [+22]